Citadel Advisors
EXAI

Citadel Advisors’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Citadel Advisors’s Portfolio EXAI Stock Details EXAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$2.44K – 15685
2024
Q3 		$2.44K Sell
500
-700
-58% -$3.67K ﹤0.01% 13750
2024
Q2 		$6.12K Sell
1,200
-17,800
-94% -$87.8K ﹤0.01% 13356
2024
Q1 		$109K Sell
19,000
-4,300
-18% -$26.7K ﹤0.01% 11242
2023
Q4 		$149K Sell
23,300
-3,800
-14% -$21.5K ﹤0.01% 10395
2023
Q3 		$122K Buy
27,100
+15,500
+134% +$100K ﹤0.01% 10639
2023
Q2 		$68.7K Sell
11,600
-2,700
-19% -$16.6K ﹤0.01% 11424
2023
Q1 		$75.8K Sell
14,300
-1,100
-7% -$7.46K ﹤0.01% 11636
2022
Q4 		$82.1K Sell
15,400
-4,100
-21% -$25.9K ﹤0.01% 11493
2022
Q3 		$160K Buy
19,500
+6,200
+47% +$62.5K ﹤0.01% 10637
2022
Q2 		$145K Buy
+13,300
New +$159K ﹤0.01% 11017

Other funds holding EXAI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Citadel Advisors's EXAI Position: Q4 2024 in Review

Citadel Advisors sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2024, closing a stake of 60,997 shares — an estimated $298K sold.

Citadel Advisors first reported a position in EXAI in Q1 2022 and held it in 5 quarters. The position peaked at $629K in Q4 2022. 1 fund tracked by Wall St. Rank holds EXAI as of Q4 2024.

  • Citadel Advisors reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 60,997 Exscientia Plc American Depositary Shares shares in Q4 2024, an estimated $298K.
  • Citadel Advisors first reported a position in Exscientia Plc American Depositary Shares in Q1 2022 and held it in 5 quarters.
  • Citadel Advisors's Exscientia Plc American Depositary Shares position peaked at $629K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.